healthcare › ... › about-ovarian-cancer
… Gynecologic oncologists at the Dan L Duncan Comprehensive Cancer Center at Baylor St. Luke’s Medical … Center are experts in the treatment of ovarian cancer. Our team is at the forefront of innovative therapies, giving patients access to … cancer in most cases.  Ovarian cancer is the seventh most common cancer among women and causes more deaths than any …
research › faculty-labs › integrative-analysis-of-lung-cancer-etiology-and-risk-consortium
… models. Within Project 2 we will systematically evaluate a comprehensive panel of promising risk biomarkers using pre- … 46,057 screening individuals (including 9,759 in Canada, 26,722 in NLST, and 9,576 in Europe. The clinical utility of … of these analyses we will (4) develop a risk calculator for use in clinical settings. Improving personalized risk …
news › trish-fellowship-seeks-to-train-space-health-scientists
… The Translational Research Institute for Space Health (TRISH) at Baylor College of Medicine, with … in TRISH’s Academy of Bioastronautics , a mentorship community for space health professionals, and receive a … through nspires.nasaprs.com will be due on January 26, 2023.   Supported by the NASA Human Research Program, …
healthcare › clinical-trials › h-43036
… The purpose of this study is to look for new ways to treat Treatment-Resistant Depression (TRD). … could be up to 18 months and involves: a screening visit, two baseline visits, two surgeries with a 10-day … the DBS device and follow up visits. Participants will be compensated for their time. See NCT listing . Site: Baylor …
healthcare › clinical-trials › h-43567
… of Health.  What does the study entail?  Five in-person visits at our clinic and monthly online check-ins. Each … last about five minutes. Study participation will last for two years. At each visit, participants will be asked to complete questionnaires and a brief physical exam. At every …
news › it-takes-cellular-teamwork-to-heal-the-intestine
… in repairing it through broad coordinated responses that ultimately heal the damaged tissue. The researchers also … often are associated with damage to the epithelium, which compromises its functions, including digestion of food and … can lead to improved therapies. Intestinal healing requires teamwork The internal surface of the intestines is lined …
healthcare › find-a-physician
… No matter where you see us, you’ll receive coordinated, compassionate care from experts in many specialties. To meet our doctors delivering: Comprehensive cancer care , visit: Dan L Duncan Comprehensive Cancer Center Obstetric … care visit: Texas Children’s Hospital Pavilion for Women Pediatric care visit: Texas Children’s Hospital …
healthcare › clinical-trials › h-51478
… Subjects will be assessed during the Screening and Baseline Visits to determine eligibility for the study. Once eligible, 6 Treatment Period visits to … drug tolerability, monitor AEs, and document changes to concomitant medications. Subjects who discontinue study drug …
research › ... › brendan-lee-lab-publications
… J Clin Invest . 2017 Apr 3;127(4):1475-1484. Pubmed PMID: 28263186 Tao J, Jiang MM, Jiang L, Salvo JS, Zeng HC, Dawson … F, Lee BH. Notch Activation as a Driver of Osteogenic Sarcoma. Cancer Cell . 2014 Sep 8;26(3):390-401. Pubmed PMID: … TK, Ambrose C, Eyre D, Bächinger HP, Lee B. Excessive transforming growth factor-β signaling is a common mechanism in …
news › participants-needed-for-hsdd-drug-study
… by mouth once a night every night.   Inclusion criteria for the study consists of men ages 18 to 69 years old. Based … throughout the study and 30 days after final study visit Willing to give informed consent   Participants are … that includes a physical, vital signs, blood drawings, concomitant medications (medication participants are taking …
Back to topback-to-top